Commission incorporates Parliament views in revised FP7 proposal

The European Commission has adopted an amended proposal for the Seventh Framework Programme (FP7), which seeks to incorporate amendments made by the European Parliament and the Council of Ministers in their first readings. The Commission reports that the revised proposals "take up in spirit and content if not necessarily always with the exact wording, to a large proportion the position taken by the other institutions".

The Commission adopted its original FP7 proposal in April 2005, while the budgetary aspects to the programme were adopted in May 2006, following agreement on the EU's Financial Perspectives for 2007 to 2013. The Parliament adopted the proposals by a broad majority in June 2006, proposing some 1700 amendments.

The themes set to receive funding under the Cooperation programme remain the same, with a number of clarifications, specifying areas in which research will be funded. These range from healthy ageing and infectious diseases to soil fertility, the sustainability of fisheries, platforms for software and services and nano-composites.

On Joint Technology Initiatives (JTIs), long-term public-private partnerships to boost technology in specific fields, the Commission accepts modifications on the criteria to be used for identifying potential JTIs, as well as their organisation and implementation.

For example, the new proposal adds that when assessing the need for a JTI: the existence of a genuine societal need and benefit; the scale of the impact on industrial competitiveness and growth; and the inability of existing instruments to achieve the objective should all be taken into account.

The amended proposal also emphasises that small and medium sized enterprises (SMEs), technology transfer and education should not be neglected by JTIs. The organisation of JTIs should ensure that "participation in their projects is open to a wide range of participants throughout Europe, and in particular SMEs".

The Commission also incorporates important clarifications on the European Research Council (ERC), and in particular on the term of office, the renewal and the role of the Scientific Council, the management and staffing arrangements, and the independent review of the ERC.

MEPs had requested a review of the ERC in 2008. Speaking to the Parliament during a debate on FP7, EU Science and Research Commissioner Janez Potocnik suggested that this would be too soon. The revised proposal states that the review will be carried out 'no later than 2010'.

The new document adds that the ERC shall have the ability to conduct its own strategic studies to prepare and support its operational activities.

Ethics were a major consideration for many parliamentarians, and the revised proposal seeks to allay concerns by specifying which areas will not receive any funding under FP7. These are human cloning for reproductive purposes, research intended to modify the genetic heritage of human beings which could make such changes heritable, and research intended to create human embryos solely for the purpose of research or the purpose of stem cell procurement.

To follow the debate on FP7, please visit:

http://cordis.europa.eu/fp7/home.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...